Gara Jalqabaatti › Lymphoma Follicular › Illinois › Chicago
Qorannoo klinikaalii Lymphoma Follicular Chicago, IL keessatti
Qorannoo 12 Lymphoma Follicular f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Illinois, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
- The University of Chicago Medical Center (UCMC), Chicago
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Northwestern Memorial Hospital, Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Chicago
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Namoota walitti qabaa jiraSadarkaa 3
- University of Chicago, Chicago
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Namoota walitti qabaa jiraSadarkaa 2
- Ruth M. Rothstein CORE Center, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- The University of Chicago Medical Center, Chicago
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern Memorial Hospital, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chicago
Qorannoo Lymphoma Follicular magaalota biroo keessatti
- New York City, NYQorannoo 24
- Milwaukee, WIQorannoo 19
- Nashville, TNQorannoo 18
- Houston, TXQorannoo 18
- Boston, MAQorannoo 17
- Baldwin Park, CAQorannoo 16
- Seattle, WAQorannoo 15
- Durham, NCQorannoo 15
- Salt Lake City, UTQorannoo 13
- Columbus, OHQorannoo 13
- San Antonio, TXQorannoo 12
- Philadelphia, PAQorannoo 12
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Saree (Gosoota Hunda)Qorannoo 51
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.